You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

heregulin

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)

Terminated
Has Results
  • Non-Small Cell Lung Cancer
  • +3 more
  • Tucson, Arizona
  • +34 more
Oct 11, 2021

Heart Failure With Reduced Ejection Fraction Trial in United States (JK07, Matching Placebo)

Active, not recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Tucson, Arizona
  • +6 more
Jan 30, 2023

Metastatic Breast Cancer Trial in Worldwide (Seribantumab, Fulvestrant, Placebo)

Terminated
Has Results
  • Metastatic Breast Cancer
  • Chandler, Arizona
  • +59 more
Aug 20, 2020

Carcinoma Breast Stage I, HER2 Positive Breast Cancer Trial in Mumbai (Trastuzumab, Placebo)

Recruiting
  • Carcinoma Breast Stage I
  • HER2 Positive Breast Cancer
  • Mumbai, India
    Tata Memorial Centre
Apr 26, 2022

Carcinoma Cervix,Stage III Trial in Mumbai (Nelfinavir, Cisplatin, Pelvic EBRT and Brachytherapy)

Recruiting
  • Carcinoma Cervix,Stage III
  • Mumbai, Maharashtra, India
    Tata Memorial Centre
Feb 18, 2022

Head and Neck Tumors Trial in Worldwide (Patritumab, Cetuximab, Cisplatin)

Terminated
Has Results
  • Head and Neck Neoplasms
  • Brussels, Belgium
  • +33 more
Dec 12, 2018

Tumors, Breast Trial in Japan (lapatinib)

Completed
Has Results
  • Neoplasms, Breast
  • Ehime, Japan
  • +8 more
Aug 30, 2018

Lung Cancer, NSCLC Trial in Worldwide (Patritumab, Erlotinib, Placebo)

Terminated
Has Results
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • Glendale, Arizona
  • +110 more
Dec 22, 2017

Colorectal Tumors, Gastrointestinal Tumors, Pancreatic Tumors Trial in Nijmegen, Amsterdam (Afatinib, Selumetinib, Docetaxel)

Unknown status
  • Colorectal Neoplasms
  • +3 more
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Aug 24, 2018

Pancreatic Cancer Trial in Worldwide (MM-141, Placebo, Gemcitabine)

Completed
  • Pancreatic Cancer
  • Gilbert, Arizona
  • +65 more
Sep 17, 2018

Colorectal Cancer, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (MM-151, MM-121, MM-141)

Terminated
  • Colorectal Cancer
  • +2 more
  • Aurora, Colorado
  • +4 more
Aug 31, 2017

Her2 Amplified Solid Tumors, Metastatic Breast Cancer Trial in United States (MM-111)

Completed
Has Results
  • Her2 Amplified Solid Tumors
  • Metastatic Breast Cancer
  • Los Angeles, California
  • +3 more
Dec 30, 2014

Breast Tumors Trial in Indianapolis, Boston, Salt Lake City (MM-111 + Herceptin)

Completed
Has Results
  • Breast Neoplasms
  • MM-111 + Herceptin
  • Indianapolis, Indiana
  • +2 more
Dec 18, 2014

NSCLC Trial in Worldwide (MM-121, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +37 more
Jul 12, 2016

Her2 Negative Breast Cancer Patients Trial in Worldwide (MM-121, Placebo, Exemestane)

Completed
Has Results
  • Her2 Negative Breast Cancer Patients
  • Birmingham, Alabama
  • +32 more
Apr 11, 2016

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in United States (MM-121, Paclitaxel)

Completed
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • Glendale, Arizona
  • +9 more
Apr 11, 2016

Metastatic Breast Cancer Trial in Italy (Fulvestrant, Lapatinib, Aromatase Inhibitors)

Unknown status
  • Metastatic Breast Cancer
  • Fabriano, Ancona, Italy
  • +68 more
Jun 14, 2016

Metastatic Breast Cancer Trial in United States (Letrozole, Trastuzumab)

Completed
  • Metastatic Breast Cancer
  • Washington, District of Columbia
  • +3 more
Sep 12, 2014

Breast Cancer Trial in Austria (Trastuzumab, Docetaxel, Trastuzumab, Docetaxel, Bevacizumab, Trastuzumab+Docetaxel+NPLD)

Completed
  • Breast Cancer
  • Trastuzumab, Docetaxel
  • +3 more
  • Graz, Styria, Austria
  • +10 more
May 12, 2014

Advanced Solid Tumors Trial in United States (U3-1287 (AMG888))

Completed
  • Advanced Solid Tumors
  • U3-1287 (AMG888)
  • Boston, Massachusetts
  • +5 more
Jul 28, 2010